Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of the long pentraxin PTX3 for the treatment of diseases caused by an altered activation of the growth factor FGF-2

Use of the long pentraxin PTX3 for the treatment of diseases caused by an altered activation of the growth factor FGF-2

US Patent 7858577 · Granted Dec 28, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-human migration stimulating factor (MSF) and uses thereof2022
Anti-human migration stimulating factor (MSF) and uses thereof2022
Diagnostic test for inflammatory endothelial dysfunctions in pregnancies2015
Permanent magnet rotor for a rotary electric machine2015
FGF2-binding peptides and uses thereof2011
FGF2-binding peptides and uses thereof2011
Methods of making an antibody that binds a chemerin polypeptide2011
Pharmaceutical compositions containing the long pentraxin PTX32011
Pharmaceutical compositions containing the long pentraxin PTX32011
Nucleic acids encoding ChemerinR ligands2011
Monoclonal antibodies, hybridomas, improved method for determining the protein P2011
Monoclonal antibodies that bind Chemerin polypeptide2010